Rothenberg Mace 4
4 · Tango Therapeutics, Inc. · Filed Nov 18, 2024
Insider Transaction Report
Form 4
Rothenberg Mace
Director
Transactions
- Purchase
Common Stock
2024-11-18$3.78/sh+10,000$37,800→ 31,250 total - Purchase
Common Stock
2024-11-14$3.62/sh+10,000$36,200→ 21,250 total